IBDEI0JM ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19771,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,19772,0)
 ;;=I07.9^^86^993^22
 ;;^UTILITY(U,$J,358.3,19772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19772,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,19772,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,19772,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,19773,0)
 ;;=I08.0^^86^993^16
 ;;^UTILITY(U,$J,358.3,19773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19773,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,19773,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,19773,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,19774,0)
 ;;=I09.89^^86^993^17
 ;;^UTILITY(U,$J,358.3,19774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19774,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,19774,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,19774,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,19775,0)
 ;;=I47.1^^86^993^24
 ;;^UTILITY(U,$J,358.3,19775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19775,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,19775,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,19775,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,19776,0)
 ;;=I48.0^^86^993^15
 ;;^UTILITY(U,$J,358.3,19776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19776,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,19776,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,19776,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,19777,0)
 ;;=I49.5^^86^993^23
 ;;^UTILITY(U,$J,358.3,19777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19777,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,19777,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,19777,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,19778,0)
 ;;=I49.8^^86^993^3
 ;;^UTILITY(U,$J,358.3,19778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19778,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,19778,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,19778,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,19779,0)
 ;;=I49.9^^86^993^2
 ;;^UTILITY(U,$J,358.3,19779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19779,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,19779,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,19779,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,19780,0)
 ;;=R00.1^^86^993^1
 ;;^UTILITY(U,$J,358.3,19780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19780,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,19780,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,19780,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,19781,0)
 ;;=I34.1^^86^993^14
 ;;^UTILITY(U,$J,358.3,19781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19781,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,19781,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,19781,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,19782,0)
 ;;=D68.4^^86^994^1
 ;;^UTILITY(U,$J,358.3,19782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19782,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,19782,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,19782,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,19783,0)
 ;;=D59.9^^86^994^2
 ;;^UTILITY(U,$J,358.3,19783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19783,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,19783,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,19783,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,19784,0)
 ;;=C91.00^^86^994^5
 ;;^UTILITY(U,$J,358.3,19784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19784,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,19784,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,19784,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,19785,0)
 ;;=C91.01^^86^994^4
 ;;^UTILITY(U,$J,358.3,19785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19785,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,19785,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,19785,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,19786,0)
 ;;=C92.01^^86^994^7
 ;;^UTILITY(U,$J,358.3,19786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19786,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,19786,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,19786,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,19787,0)
 ;;=C92.00^^86^994^8
 ;;^UTILITY(U,$J,358.3,19787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19787,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,19787,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,19787,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,19788,0)
 ;;=C92.61^^86^994^9
 ;;^UTILITY(U,$J,358.3,19788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19788,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,19788,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,19788,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,19789,0)
 ;;=C92.60^^86^994^10
 ;;^UTILITY(U,$J,358.3,19789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19789,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,19789,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,19789,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,19790,0)
 ;;=C92.A1^^86^994^11
 ;;^UTILITY(U,$J,358.3,19790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19790,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,19790,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,19790,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,19791,0)
 ;;=C92.A0^^86^994^12
 ;;^UTILITY(U,$J,358.3,19791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19791,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,19791,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,19791,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,19792,0)
 ;;=C92.51^^86^994^13
 ;;^UTILITY(U,$J,358.3,19792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19792,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,19792,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,19792,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,19793,0)
 ;;=C92.50^^86^994^14
 ;;^UTILITY(U,$J,358.3,19793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19793,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,19793,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,19793,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,19794,0)
 ;;=C94.40^^86^994^17
 ;;^UTILITY(U,$J,358.3,19794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19794,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,19794,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,19794,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,19795,0)
 ;;=C94.42^^86^994^15
 ;;^UTILITY(U,$J,358.3,19795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19795,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,19795,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,19795,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,19796,0)
 ;;=C94.41^^86^994^16
 ;;^UTILITY(U,$J,358.3,19796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19796,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,19796,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,19796,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,19797,0)
 ;;=D62.^^86^994^18
 ;;^UTILITY(U,$J,358.3,19797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19797,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,19797,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,19797,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,19798,0)
 ;;=C92.41^^86^994^19
 ;;^UTILITY(U,$J,358.3,19798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19798,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,19798,1,4,0)
 ;;=4^C92.41
 ;;^UTILITY(U,$J,358.3,19798,2)
 ;;=^5001802
 ;;^UTILITY(U,$J,358.3,19799,0)
 ;;=C92.40^^86^994^20
 ;;^UTILITY(U,$J,358.3,19799,1,0)
 ;;=^358.31IA^4^2
